Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 6:25 pm Purchase |
2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Citadel Advisors LLC | 3,465,307 4.100% |
54,543![]() (+1.60%) |
Filing History |
2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Schonfeld Strategic Advisors LLC | 5,234,508 6.160% |
5,234,508![]() (New Position) |
Filing History |
2025-02-11 4:00 pm Purchase |
2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Soleus Capital Master Fund, L.P. | 8,142,500 9.600% |
1,918,956![]() (+30.83%) |
Filing History |
2025-02-05 5:28 pm Purchase |
2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
BLACKROCK INC BLK |
5,743,482 6.800% |
1,044,711![]() (+22.23%) |
Filing History |
2024-11-15 10:35 am Sale |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
Point72 Asset Management, L.P. | 2,894,093 3.500% |
-1,027,133![]() (-26.19%) |
Filing History |
2024-11-14 7:00 pm Purchase |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
Vivo Capital Fund VIII L.P. | 4,597,243 5.400% |
4,597,243![]() (New Position) |
Filing History |
2024-11-14 5:51 pm Sale |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
Venrock Healthcare Capital Partners III L.P. | 3,516,889 4.990% |
-980,228![]() (-21.80%) |
Filing History |
2024-11-14 4:15 pm Sale |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
Fairmount Funds Management LLC | 0 0.000% |
-6,632,015![]() (Position Closed) |
Filing History |
2024-11-14 3:41 pm Sale |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% |
-5,837,126![]() (Position Closed) |
Filing History |
2024-11-14 3:30 pm Purchase |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
Soleus Capital Master Fund, L.P. | 6,223,544 7.300% |
2,882,424![]() (+86.27%) |
Filing History |
2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
BLACKROCK INC BLK |
4,698,771 5.600% |
0 (Unchanged) |
Filing History |
2024-11-05 4:15 pm Sale |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
Integrated Core Strategies (US) LLC | 1,628,534 1.900% |
-1,851,096![]() (-53.20%) |
Filing History |
2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
BLACKROCK INC BLK |
4,698,771 5.600% |
1,577,906![]() (+50.56%) |
Filing History |
2024-09-16 8:29 pm Unchanged |
2024-09-12 | 13D | Terns Pharmaceuticals, Inc. TERN |
ORBIMED ADVISORS LLC | 7,562,971 9.000% |
0 (Unchanged) |
Filing History |
2024-07-22 4:18 pm Purchase |
2024-07-10 | 13G | Terns Pharmaceuticals, Inc. TERN |
Citadel Advisors LLC | 3,410,764 5.300% |
3,410,764![]() (New Position) |
Filing History |
2024-07-18 5:33 pm Sale |
2024-07-16 | 13D | Terns Pharmaceuticals, Inc. TERN |
ORBIMED ADVISORS LLC | 7,562,971 11.700% |
-56,164![]() (-0.74%) |
Filing History |
2024-06-07 1:30 pm Sale |
2024-05-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
BLACKROCK INC BLK |
3,120,865 4.800% |
-288,113![]() (-8.45%) |
Filing History |
2024-06-07 08:30 am Purchase |
2024-06-06 | 13G | Terns Pharmaceuticals, Inc. TERN |
Soleus Capital Master Fund, L.P. | 3,341,120 5.200% |
3,341,120![]() (New Position) |
Filing History |
2024-03-07 4:15 pm Purchase |
2024-03-06 | 13G | Terns Pharmaceuticals, Inc. TERN |
Point72 Asset Management, L.P. | 3,921,226 6.300% |
3,921,226![]() (New Position) |
Filing History |
2024-02-14 8:38 pm Purchase |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Venrock Healthcare Capital Partners III L.P. | 4,497,117 7.300% |
789,226![]() (+21.29%) |
Filing History |